Abcellera Biologics 

Abcellera Biologics 

Yahoo Finance • 16 days ago

FDA names acting heads of drug and vaccine units to permanent roles

[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House advisor Heidi Overton as the agency's nex... Full story

Yahoo Finance • last month

AbCellera Biologics prices oversubscribed $200M offering at $9.75/share

AbCellera Biologics (ABCL [https://seekingalpha.com/symbol/ABCL]) announced the pricing of its oversubscribed underwritten public offering [https://seekingalpha.com/pr/20617674-abcellera-announces-pricing-of-oversubscribed-200-million-publ... Full story

Yahoo Finance • 2 months ago

This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 36% on Good News.

New data show a single dose of AbCellera’s menopause treatment, ABCL635, reduces how often patients with menopause experience hot flashes. Continue Reading... Full story

Yahoo Finance • 2 months ago

AbCellera's ABCL635 Delivers Strong Phase 2 Data; Stock Jumps 33%

(RTTNews) - AbCellera Biologics Inc. (ABCL) announced positive top-line results from the Phase 2 portion of its Phase 1/2 clinical trial evaluating ABCL635, an investigational NK3R antagonist antibody for moderate-to-severe vasomotor sympt... Full story

Yahoo Finance • 2 months ago

AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points AbCellera Biologics Inc (NASDAQ:ABCL) complete... Full story

Yahoo Finance • 2 months ago

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) heads into its fourth-quarter and full-year results with fresh index inclusion, an expanded patent estate, and AI-designed programs aimed at two of medicin... Full story

Yahoo Finance • 3 months ago

Strong Buy at under $10: The highest Quant-rated bargain stocks right now

[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Seeking Alpha's Quant Rating system has identified a group of sub-$10 stocks that score near the very top of its quantitative rankings, a rare distinction given that penny... Full story

Yahoo Finance • 3 months ago

Is MannKind Corporation (MNKD) A Good Stock To Buy Now?

Is MNKD a good stock to buy? We came across a bullish thesis on MannKind Corporation on BioEquity Watch's Substack. In this article, we will summarize the bulls' thesis on MNKD. MannKind Corporation's share was trading at $3.8400 as of Jun... Full story

Yahoo Finance • 3 months ago

Health Care had the best week vs. the S&P 500 on record

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The health care sector (XLV [https://seekingalpha.com/symbol/XLV]) had its best week against the S&P 500 (SP500 [htt... Full story

Yahoo Finance • 3 months ago

Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera

(RTTNews) - This week, the biotech sector saw FDA approvals, alongside study halts, layoffs, strategic collaborations, acquisitions, deal closures, and encouraging data readouts. Positive clinical readouts spanning therapeutic areas inclu... Full story

Yahoo Finance • 4 months ago

7 Healthcare AI Stocks Under $50 With Huge Upside Potential

Quick Read Dislocation between share price and product progress is exactly the kind of setup retail investors should scan for. Here are seven healthcare AI stocks trading under $50 where the bull case is grounded, not hype. The analyst wh... Full story

Yahoo Finance • 5 months ago

Why AbCellera Biologics (ABCL) Is Up 16.1% After ABCL635 Trial Momentum Builds Ahead Of Data

In recent days, attention has centred on AbCellera Biologics ahead of its upcoming Q1 earnings call and the May 11, 2026 Phase 1 interim data update for ABCL635, a clinical candidate targeting menopause-related vasomotor symptoms. Investor... Full story

Yahoo Finance • 5 months ago

JonesResearch Initiates Coverage of AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best stocks under $5 with huge upside potential. On April 9, JonesResearch initiated coverage of AbCellera Biologics Inc. (NASDAQ:ABCL) with a Buy rating and set a $11 price target. The... Full story

Yahoo Finance • 6 months ago

AbCellera (ABCL): Among the Stocks That Could 10x Over the Next 5 Years

AbCellera Biologics Inc. (NASDAQ:ABCL) ranks among the stocks that could 10x over the next 5 years. On March 17, AbCellera Biologics Inc. (NASDAQ:ABCL) outlined its vision at the KeyBanc Capital Markets Healthcare Forum 2026, emphasizing i... Full story

Yahoo Finance • 7 months ago

MannKind Corporation (MNKD): A Bull Case Theory

We came across a bullish thesis on MannKind Corporation on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on MNKD. MannKind Corporation's share was trading at $3.5000 as of February 25th. MNKD’s trailing and forw... Full story

Yahoo Finance • 7 months ago

3 Promising Penny Stocks With At Least $600M Market Cap

As U.S. stock indexes have started February on a high note, with the Dow Jones Industrial Average and S&P 500 showing impressive gains, investors are closely watching for opportunities in various market segments. Penny stocks, while often... Full story

Yahoo Finance • 8 months ago

AbCellera Biologics Inc. (ABCL): A Bull Case Theory

We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.'s share was trading at $3.6200 as of January 21st. ABCL’s tra... Full story

Yahoo Finance • 9 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index and the State Stree PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 9 months ago

AbCellera settles patent litigation with Bruker over microfluidic device tech

[The Patent Application Process Important Paperwork and Necessary Tools for Success] * Bruker Corp. (BRKR [https://seekingalpha.com/symbol/BRKR]) will pay AbCellera Biologics (ABCL [https://seekingalpha.com/symbol/ABCL]) $36M plus futur... Full story

Yahoo Finance • 9 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

VANCOUVER, British Columbia, December 18, 2025--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that it has entered into a settlement and patent license agreement with Bruker Corporation, resolving the patent litigation between t... Full story